ROBINSON PHARMA
According to U.S. Department of Labor enforcement records, ROBINSON PHARMA — a manufacturing facility located at 3330 S. HARBOR BLVD., SANTA ANA, CA 92704 — was the subject of a formal OSHA inspection that resulted in 2 citation(s) and cumulative proposed penalties of $54,000.00. The inspection case was opened on 2017-06-02.
Cumulative penalties significantly exceed the national median for OSHA enforcement actions. The penalty amount suggests multiple high-gravity citations, indicating conditions that presented a substantial probability of death or serious physical harm to employees.
Industry Benchmark: The total penalty of $54,000.00 is more than 6.4× the national average of $8,414.32 for facilities in the Manufacturing sector (NAICS 325411). This sector encompasses 52,095 inspected facilities nationwide with aggregate penalties totaling $438.3M.
State Context: Within CA, this facility's penalty places it at the 100th percentile among 184,062 inspected facilities. The statewide average penalty is $3,010.44.
Citation Analysis: The inspection produced 2 citations spanning 0 distinct OSHA regulatory standards. The citation breakdown includes: 1 repeat — A substantially similar violation was found during a previous inspection and the original citation has become a final order. 1 serious — A workplace hazard that could cause death or serious physical harm exists, and the employer knew or should have known about the condition.
Enforcement Timeline: Citations were issued beginning August 14, 2017 with the latest abatement deadline set for August 28, 2017. Of the 2 total citations, 0 (0%) have been marked as abated in DOL records, which may indicate ongoing compliance gaps requiring further regulatory attention.
Penalty Assessment: The per-citation average of $27,000.00 exceeds OSHA's FY2024 statutory maximum of $16,131 for serious violations, indicating the presence of willful or repeat classifications that carry enhanced penalty authority under Section 17 of the OSH Act.
Robinson Pharma’s 2017 enforcement record revealed a troubling intersection of systemic management failures and high